RT Journal Article
T1 Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS).
A1 Benavent, Marta
A1 Sastre, Javier
A1 Escobar, Ignacio García
A1 Segura, Angel
A1 Capdevila, Jaume
A1 Carmona, Alberto
A1 Sevilla, Isabel
A1 Alonso, Teresa
A1 Crespo, Guillermo
A1 García, Lourdes
A1 Canal, Neus
A1 de la Cruz, Guillermo
A1 Gallego, Javier
K1 Clinical utility
K1 Communication
K1 Health-related quality of life
K1 Neuroendocrine tumours
K1 QLQ-GINET21 questionnaire
AB Patient-reported outcome measures can provide clinicians with valuable information to improve doctor-patient communication and inform clinical decision-making. The aim of this study was to evaluate the physician-perceived utility of the QLQ-GINET21 in routine clinical practice in patients with gastrointestinal neuroendocrine tumours (GI-NETs). Secondary aims were to explore the patient, clinician, and/or centre-related variables potentially associated with perceived clinical utility. Non-interventional, cross-sectional, multicentre study conducted at 34 hospitals in Spain and Portugal (NCT02853422). Patients diagnosed with GI-NETs completed two health-related quality of life (HRQoL) questionnaires (QLQ-C30, QLQ-GINET21) during a single routine visit. Physicians completed a 14-item ad hoc survey to rate the clinical utility of QLQ-GINET21 on three dimensions: 1)therapeutic and clinical decision-making, 2)doctor-patient communication, 3)questionnaire characteristics. A total of 199 patients at 34 centres were enrolled by 36 participating clinicians. The highest rated dimension on the QLQ-GINET21 was questionnaire characteristics (86.9% of responses indicating "high utility"), followed by doctor-patient communication (74.4%), and therapeutic and clinical decision-making (65.8%). One physician-related variable (GI-NET patient volume > 30 patients/year) was associated with high clinical utility and two variables (older age/less experience treating GI-NETs) with low clinical utility. Clinician-perceived clinical utility of QLQ-GINET21 is high. Clinicians valued the instruments' capacity to provide a better understanding of patient perspectives and to identify the factors that had the largest influence on patient HRQoL.
YR 2021
FD 2021-01-30
LK http://hdl.handle.net/10668/17070
UL http://hdl.handle.net/10668/17070
LA en
DS RISalud
RD Apr 9, 2025